What’s new at the Rosalind & Morris Goodman Cancer Institute?

The Rosalind and Morris Goodman Cancer Institute (GCI), including members of the Departments of Biochemistry and Physiology, recently came together to celebrate the well-deserved tenure appointments of Professors Lawrence Kazak, Daniela Quail, and Logan Walsh.

October is the awareness month for breast cancer, a disease which has been a major research focus at the Rosalind and Morris Goodman Cancer Institute (GCI) since its inception. World-leading scientists at the GCI have led new discoveries in breast cancer, developed breast cancer models used by the global research community, and pioneered an understanding of the importance of the breast tumor environment on cancer initiation and progression.

Members of the Rosalind and Morris Goodman Cancer Institute (GCI) joined our community in showing support for the Terry Fox Foundation at the 2024 Montreal Terry Fox Run.

The Rosalind and Morris Goodman Cancer Institute (GCI)’s distinguished alumna, Sylvia Andrzejewski, has made significant strides in the field of cancer research and drug development. From lab benches to leadership in biotech, we had the pleasure of catching up with Sylvia to learn more about her career in industry.

The Rosalind and Morris Goodman Cancer Institute (GCI) and Department of Biochemistry are mourning the loss of Philip E. Branton, PhD, a dear colleague, friend, and brilliant scientist whose career profoundly shaped cancer research.

The week of September 16-20 is Postdoc Appreciation Week, an occasion the Rosalind and Morris Goodman Cancer Institute (GCI) is marking by reflecting on the contributions of our post-doctoral researchers.

The Rosalind and Morris Goodman Cancer Institute (GCI) is delighted to announce the GCI's newest member, Prof. Hannah Garner, effective August 30th, 2024.  Hannah joins McGill University as an Assistant Professor, jointly appointed in the Department of Microbiology and Immunology (MIMM) and the GCI.

During Prostate Cancer Awareness Month, scientists at the Rosalind and Morris Goodman Cancer Research Institute (GCI) are sharing the crucial role that their research plays in improving prostate cancer patient outcomes.

September is Ovarian Cancer Awareness Month, a time for raising awareness about one of the deadliest gynecological cancers. Principal investigators Sidong Huang and Yojiro Yamanaka have published important studies addressing challenges in ovarian cancer diagnosis and treatment.